Join us on March 7 for our Educated Patient Summit on Breast Cancer taking place in Miami, FL! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Prostate Cancer

Feature Video
Receiving a diagnosis of prostate cancer can be frightening and confusing. Understanding the details of your specific cancer and how they relate to your prognosis and treatment planning is an important first step toward shared decision-making between you and your physicians. In these CURE Connections programs you will learn the meaning of the PSA test, prostate cancer staging and grading, and how these factors are used to determine which treatment approach is right for you. Management of prostate cancer related symptoms, available treatments, and how to deal with side effects are also discussed. In addition, you will hear from patients and caregivers about their personal experiences with prostate cancer.
Kristie L. Kahl and Lisa Schlager
Lisa Schlager, vice president of public policy at FORCE: Facing Our Risk Empowered, sits down with CURE® to discuss genetic mutations in men that are not being addressed.
Kristie L. Kahl
A study of the Veterans Affairs health system found that, despite trends suggesting otherwise, African American men with prostate cancer had similar survival outcomes, compared with non-Hispanic White men.
 
Kristie L. Kahl
Researchers found that men with prostate cancer who consumed a diet high in vegetable did not experience clinical benefit; however, overall health benefits were seen.
Kristie L. Kahl
How providers communicate medical bills to payers and patients, mandated by the US Centers for Medicare & Medicaid Services, still did not help patients and health care professionals in understanding differences in cost.
Kristie L. Kahl
Researchers found that combining family history and genetic risk scores to determine inherited risk for prostate cancer could personalize screening strategies for men.
Kristie L. Kahl
A modified citrus pectin, naturally found in the peel of citrus fruits, showed continued benefit among men with prostate cancer.
 
Kristie L. Kahl
Men with metastatic castration-sensitive prostate cancer will now have a fourth treatment option to consider.
 
Kristie L. Kahl
The Food and Drug Administration approved Xtandi for the treatment of patients with metastatic castration-sensitive prostate cancer.
 
Tom Castles
New research suggests men with infertility could face a 30% to 60% higher risk of prostate cancer.
 
Jessica Skarzynski
Although one in nine men will receive a prostate cancer diagnosis in his lifetime, cutting-edge research has allowed more men to live longer or even be cured.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×